Evidence map›Paper›PMID 25224612›Full record

ArticleJournal of the International AIDS Society2014

Communicating about microbicides with women in mind: tailoring messages for specific audiences.

Sekou Sidibe, Allison P Pack, Elizabeth E Tolley, Elizabeth Ryan, Caroline Mackenzie, Emily Bockh, George Githuka

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
7.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Sexual Pleasure and Healthcare Settings: Focusing on Pleasure to Improve Healthcare Delivery and Utilization.International journal of sexual health : official journal of the World Association for Sexual Health · 2021
    Article
  3. Article
  4. Article
  5. Women and ARV-based HIV prevention - challenges and opportunities.Journal of the International AIDS Society · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Sekou SidibeSocial & Behavioural Health Sciences, FHI360, Durham, NC, USA; sidibes1@gmail.com.
Allison P PackSocial & Behavioural Health Sciences, FHI360, Durham, NC, USA.
Elizabeth E TolleySocial & Behavioural Health Sciences, FHI360, Durham, NC, USA.
Elizabeth RyanSocial Marketing and Communication, FHI 360, Washington, DC, USA.
Caroline MackenzieResearch, FHI 360, Nairobi, Kenya.
Emily BockhResearch, FHI 360, Nairobi, Kenya.
George GithukaNational AIDS and STI Control Programme, Nairobi, Kenya.
Family Health International 360 · USNational Aids Control Council · KE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCurrent HIV prevention options are unrealistic for most women; however, HIV prevention research has made important strides, including on-going development of antiretroviral-based vaginal microbicide gels. Nevertheless, social-behavioural research suggests that women's ability to access and use new HIV prevention technologies will be strongly influenced by a range of socio-cultural, gender and structural factors which should be addressed by communications and marketing strategies, so that these products can be positioned in ways that women can use them.

methodsBased on an extensive literature review and in-country policy consultation, consisting of approximately 43 stakeholders, we describe barriers and facilitators to HIV prevention, including potential microbicide use, for four priority audiences of Kenyan women (female sex workers [FSWs], women in stable and discordant relationships, and sexually active single young women). We then describe how messages that position microbicides might be tailored for each audience of women.

resultsWe reviewed 103 peer-reviewed articles and reports. In Kenya, structural factors and gender inequality greatly influence HIV prevention for women. HIV risk perception and the ability to consistently use condoms and other prevention products often vary by partner type. Women in stable relationships find condom use challenging because they connote a lack of trust. However, women in other contexts are often able to negotiate condom use, though they may face challenges with consistent use. These women include FSWs who regularly use condoms with their casual clients, young women in the initial stages of a sexual relationship and discordant couples. Thus, we consider two approaches to framing messages aimed at increasing general awareness of microbicides - messages that focus strictly on HIV prevention and ones that focus on other benefits of microbicides such as increased pleasure, intimacy or sexual empowerment, in addition to HIV prevention.

conclusionsIf carefully tailored, microbicide communication materials may facilitate product use by women who do not currently use any HIV prevention method. Conversely, message tailoring for women with high-risk perception will help ensure that microbicides are used as additional protection, together with condoms.

Indexed as

Health CommunicationAdministration, IntravaginalAdolescentAnti-Infective Agents, LocalAnti-Retroviral AgentsChemopreventionDisease Transmission, InfectiousFemaleHealth EducationHIV InfectionsHumansKenyaMalePatient Acceptance of Health CarePre-Exposure ProphylaxisYoung AdultAnti-Infective Agents, LocalAnti-Retroviral AgentscommunicationHIV preventionKenyamessagesmicrobicidewomen

Identifiers

PMID25224612
PMCPMC4163994
OpenAlexW2004080667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.